Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Balyasny Reports 7.36% Stake in Opus Genetics

Balyasny Asset Management L.P. and related reporting persons filed Amendment No. 3 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 6,120,982 shares of Opus Genetics Inc. common stock as of September 30, 2026.

Anjali Anand | 16 November 2026

Balyasny Discloses 1.26% Stake in Korsana Biosciences

Balyasny Asset Management L.P. and related reporting persons filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 572,533 shares of common stock in Korsana Biosciences, Inc. as of September 30, 2026.

Vinay Lochav | 16 November 2026

Feng Yang Reports 8.4% Stake in Intchains Group

Yang Feng 888 Capital Limited and its sole owner Feng Yang filed Amendment No. 1 to a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 5,400,000 Class A ordinary shares of Intchains Group Limited as of September 30, 2026.

Vinay Lochav | 16 November 2026

Balyasny Reports 9.99% Stake in Lexeo Therapeutics

Balyasny Asset Management L.P. and related reporting persons filed Amendment No. 5 to a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 8,196,420 shares of Lexeo Therapeutics, Inc. common stock as of September 30, 2026.

Anjali Anand | 16 November 2026

Balyasny Reports 7.94% Stake in SAB Biotherapeutics

Balyasny Asset Management L.P. and related reporting persons filed an amended beneficial ownership statement with the SEC on November 16, 2026, disclosing a 7.94% stake in SAB Biotherapeutics, Inc. (NASDAQ:SABS) as of September 30, 2026.

Manish Choudhary | 16 November 2026

Balyasny Reports 9.99% Stake in Beyond Air at 95,667 Shares

Balyasny Asset Management L.P. and related reporting persons filed Amendment No. 7 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 95,667 shares of Beyond Air, Inc. common stock as of September 30, 2026.

Anjali Anand | 16 November 2026

L1 Capital Discloses 5.1% Stake in B2Gold Corp

Australian investment manager L1 Capital Pty Ltd filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 66,721,697 common shares of B2Gold Corp as of September 30, 2026.

Nitish Kishor | 16 November 2026

L1 Capital Discloses 9% Stake in Centerra Gold

L1 Capital Pty Ltd filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 17,498,747 common shares of Centerra Gold Inc. as of September 30, 2026.

Anjali Anand | 16 November 2026

Peoples Bancorp Files S-4 to Acquire Capital Bancorp at 1.11 Exchange Ratio

Peoples Bancorp Inc. filed a Form S-4 registration statement with the SEC on November 13, 2026, initiating the joint proxy statement/prospectus process for its proposed all-stock acquisition of Capital Bancorp, Inc.

Aakashdeep | 16 November 2026

Eric Ya Shen Holds 19.5% of Vipshop in Amendment 11

Elegant Motion Holdings Limited, Eric Ya Shen, and Xiaochun Zhang filed Amendment No. 11 to Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership positions in Vipshop Holdings Limited as of September 30, 2026.

Nitish Kishor | 16 November 2026
Support

Hi! How can we help you today?

Loading…